Report Detail

Pharma & Healthcare Global Therapeutic Radiopharmaceuticals Market Growth 2019-2024

  • RnM3313418
  • |
  • 12 April, 2019
  • |
  • Global
  • |
  • 161 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

According to this study, over the next five years the Therapeutic Radiopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Therapeutic Radiopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study considers the Therapeutic Radiopharmaceuticals value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Thyroid
Bone Metastasis
Lymphoma
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Therapeutic Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Therapeutic Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Therapeutic Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Therapeutic Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Therapeutic Radiopharmaceuticals Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Therapeutic Radiopharmaceuticals Consumption 2014-2024
        • 2.1.2 Therapeutic Radiopharmaceuticals Consumption CAGR by Region
      • 2.2 Therapeutic Radiopharmaceuticals Segment by Type
        • 2.2.1 Radium-223
        • 2.2.2 Lutetium-177
        • 2.2.3 Iodine-131
        • 2.2.4 Other
      • 2.3 Therapeutic Radiopharmaceuticals Consumption by Type
        • 2.3.1 Global Therapeutic Radiopharmaceuticals Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Therapeutic Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Therapeutic Radiopharmaceuticals Sale Price by Type (2014-2019)
      • 2.4 Therapeutic Radiopharmaceuticals Segment by Application
        • 2.4.1 Thyroid
        • 2.4.2 Bone Metastasis
        • 2.4.3 Lymphoma
        • 2.4.4 Other
      • 2.5 Therapeutic Radiopharmaceuticals Consumption by Application
        • 2.5.1 Global Therapeutic Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Therapeutic Radiopharmaceuticals Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Therapeutic Radiopharmaceuticals Sale Price by Application (2014-2019)

      3 Global Therapeutic Radiopharmaceuticals by Players

      • 3.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Players
        • 3.1.1 Global Therapeutic Radiopharmaceuticals Sales by Players (2017-2019)
        • 3.1.2 Global Therapeutic Radiopharmaceuticals Sales Market Share by Players (2017-2019)
      • 3.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Players
        • 3.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Players (2017-2019)
        • 3.2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Players (2017-2019)
      • 3.3 Global Therapeutic Radiopharmaceuticals Sale Price by Players
      • 3.4 Global Therapeutic Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Therapeutic Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Therapeutic Radiopharmaceuticals Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Therapeutic Radiopharmaceuticals by Regions

      • 4.1 Therapeutic Radiopharmaceuticals by Regions
        • 4.1.1 Global Therapeutic Radiopharmaceuticals Consumption by Regions
        • 4.1.2 Global Therapeutic Radiopharmaceuticals Value by Regions
      • 4.2 Americas Therapeutic Radiopharmaceuticals Consumption Growth
      • 4.3 APAC Therapeutic Radiopharmaceuticals Consumption Growth
      • 4.4 Europe Therapeutic Radiopharmaceuticals Consumption Growth
      • 4.5 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption Growth

      5 Americas

      • 5.1 Americas Therapeutic Radiopharmaceuticals Consumption by Countries
        • 5.1.1 Americas Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
        • 5.1.2 Americas Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
      • 5.2 Americas Therapeutic Radiopharmaceuticals Consumption by Type
      • 5.3 Americas Therapeutic Radiopharmaceuticals Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Therapeutic Radiopharmaceuticals Consumption by Countries
        • 6.1.1 APAC Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
        • 6.1.2 APAC Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
      • 6.2 APAC Therapeutic Radiopharmaceuticals Consumption by Type
      • 6.3 APAC Therapeutic Radiopharmaceuticals Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Therapeutic Radiopharmaceuticals by Countries
        • 7.1.1 Europe Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
        • 7.1.2 Europe Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
      • 7.2 Europe Therapeutic Radiopharmaceuticals Consumption by Type
      • 7.3 Europe Therapeutic Radiopharmaceuticals Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Therapeutic Radiopharmaceuticals by Countries
        • 8.1.1 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Type
      • 8.3 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Therapeutic Radiopharmaceuticals Distributors
      • 10.3 Therapeutic Radiopharmaceuticals Customer

      11 Global Therapeutic Radiopharmaceuticals Market Forecast

      • 11.1 Global Therapeutic Radiopharmaceuticals Consumption Forecast (2019-2024)
      • 11.2 Global Therapeutic Radiopharmaceuticals Forecast by Regions
        • 11.2.1 Global Therapeutic Radiopharmaceuticals Forecast by Regions (2019-2024)
        • 11.2.2 Global Therapeutic Radiopharmaceuticals Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Therapeutic Radiopharmaceuticals Forecast by Type
      • 11.8 Global Therapeutic Radiopharmaceuticals Forecast by Application

      12 Key Players Analysis

      • 12.1 Bayer
        • 12.1.1 Company Details
        • 12.1.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Bayer News
      • 12.2 Novartis
        • 12.2.1 Company Details
        • 12.2.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Novartis News
      • 12.3 China Isotope & Radiation
        • 12.3.1 Company Details
        • 12.3.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 China Isotope & Radiation News
      • 12.4 Dongcheng
        • 12.4.1 Company Details
        • 12.4.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Dongcheng News
      • 12.5 Q BioMed
        • 12.5.1 Company Details
        • 12.5.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Q BioMed News
      • 12.6 Curium Pharmaceuticals
        • 12.6.1 Company Details
        • 12.6.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Curium Pharmaceuticals News
      • 12.7 Jubilant DraxImage
        • 12.7.1 Company Details
        • 12.7.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Jubilant DraxImage News
      • 12.8 Lantheus
        • 12.8.1 Company Details
        • 12.8.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Lantheus News
      • 12.9 Spectrum Pharmaceuticals
        • 12.9.1 Company Details
        • 12.9.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Spectrum Pharmaceuticals News
      • 12.10 Progenics Pharmaceuticals
        • 12.10.1 Company Details
        • 12.10.2 Therapeutic Radiopharmaceuticals Product Offered
        • 12.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Progenics Pharmaceuticals News
      • 12.11 International Isotopes

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Therapeutic Radiopharmaceuticals . Industry analysis & Market Report on Therapeutic Radiopharmaceuticals is a syndicated market report, published as Global Therapeutic Radiopharmaceuticals Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Therapeutic Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,829.18
      4,243.77
      5,658.36
      3,407.46
      5,111.19
      6,814.92
      558,845.40
      838,268.10
      1,117,690.80
      308,904.00
      463,356.00
      617,808.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report